Pharmaco-epidemiology and Drug Safety [EL012]
Monday to Friday (5 full days)
Prof. Bruno Stricker, PhD, Katia Verhamme, PhD, Sabine Straus, PhD
Erasmus MC, Rotterdam NL
- Pharmaco Epidemiology
Detailed information about this course:
Pharmaco-epidemiology plays a role of increasing importance in the field of drug safety and regulatory decision making. On the one hand, the introduction of computers into clinical practice facilitates the performance of large-scale cohort studies and nested case-control studies. On the other hand, it creates some problems regarding the quality of outcome and exposure assessment. Because the commercial consequences of pharmaco-epidemiological studies may be enormous, discussions in this area may be heated.
In this course, referring to established drug safety problems will highlight some of the complex aspects of outcome and exposure assessment in pharmaco-epidemiology.
Plenary teaching as well as computer exercises on the analysis of cohort- and case-control data.
Understanding the complex aspects of outcome and exposure assessment in pharmaco-epidemiology.
Medical doctors and pharmacists, as well as health care workers and experts from the pharmaceutical industry.
Reduction on fees
PLEASE NOTE THIS DOES NOT APPLY TO THE RESEARCH MASTERS (120 EC points)
No fees are charged for participation of Erasmus MC PhD candidates
Please note that in case of cancellation or no show, the cancellation policy applies based on the full course fee.
25% reduction for all (international) PhD students without formal appointment at Erasmus MC
Upon receipt of your application you will receive a request to upload proof of enrollment as a PhD student.